[ Price : $8.95]
FDA accepts for review a Replimune BLA resubmission for RP1 (vusolimogene oderparepvec) in combination with nivolumab for treating...[ Price : $8.95]
Roche reports new favorable data from the Phase 3 evERA Breast Cancer study of its investigational oral therapy giredestrant, used...[ Price : $8.95]
Attorneys at Hyman, Phelps & McNamara say they are encouraged by an FDA draft guidance outlining a roadmap for postapproval monito...[ Price : $8.95]
The Advanced Medical Technology Association outlines a series of recommendations aimed at strengthening U.S. leadership in medical...[ Price : $8.95]
Summit Therapeutics reports that its investigational bispecific antibody ivonescimab, when combined with chemotherapy, significant...[ Price : $8.95]
FDA approves a new indication for Novo Nordisks Rybelsus (oral semaglutide) tablets to reduce the risk of major adverse cardiovasc...[ Price : $8.95]
Kenvue urges FDA to deny a recent citizen petition requesting updates to the pregnancy warning on acetaminophen products.[ Price : $8.95]
A new report by RBC Capital Markets finds a slowdown in FDA drug approvals, a rise in rejected applications, and an increase in de...